Polysubstituted naphthenic compound and preparation method thereof

Through the nucleophilic addition reaction of cheap catalysts in cycloalkane compounds, the complex problems of precious metal catalysis and reaction in the prior art were solved, and efficient and green multifunctional cycloalkane compounds were achieved, with good functional group tolerance and Selective.

CN119080652APending Publication Date: 2024-12-06SUZHOU NOVARTIS PHARMA TECHONOLOGY CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411217538.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In the prior art, the synthesis method of cycloalkane compounds has problems such as using precious metal catalysts, high toxicity, complex reactions, and poor substrate tolerance, making it difficult to achieve high-efficiency and green multifunctional cycloalkane compounds on a large scale.

Method used

Nucleophilic addition reaction was carried out under 5% DMAP catalysis by cheap active methylene and methyl compounds and quaternary tension ring substrates, and 1,1 was obtained efficiently through one-step reaction. ,3-trisubstituted cycloalkane compounds have good selectivity and are suitable for a variety of electron-donating and donating groups.

Benefits of technology

The synthesis of polyfunctional cycloalkane compounds with high yield, green and concise yields, has good functional group tolerance, and the main products are cis products, providing a synthesis method with significant advantages in industrialization.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080652A_ABST
    Figure CN119080652A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of chemical synthesis, and particularly relates to a polysubstituted naphthenic compound and a preparation method thereof. Specifically, in the presence of a catalyst, a compound represented by a formula 1 and a compound represented by a formula 2 are subjected to a nucleophilic addition reaction to prepare a compound represented by a formula 3: # imgabs0 # in one step, and the catalyst is dimethylaminopyridine, 4-pyrrolidinyl pyridine or diisopropylethylamine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of chemical synthesis, and particularly relates to a base-catalyzed synthesis of a multi-substituted cycloalkane compound and a preparation method thereof. Background Art

[0002] Cycloalkane compounds are important structural units of natural products and other molecules of important biological significance, especially multifunctionalized cycloalkane skeletons, which are often incorporated into drug design as linkers, as shown in journal literature J.Med.Chem.2011,54,7602-7620, Future Med.Chem.2009,1,1153-1171 and J.Org.Chem.2021,86,11464-11471.

[0003]

[0004] Nowadays, the synthesis method of disubstituted cycloalkane compounds has been widely reported, as shown in the journal document Chin. J. Chem. 2022, 40, 1346-1358.

[0005]

[0006] However, the above-mentioned methods for synthesizing difunctionalized cycloalkane compounds involve the use of precious metal catalysts such as palladium, iridium, and silver, which are expensive, use a variety of reagents, and have complex ligands, which are not conducive to large-scale reactions. At the same time, the products of these reactions are mostly 1,2-disubstituted cycloalkane compounds, and 1,3-functionalized cycloalkane products cannot be obtained.

[0007] In 2018, Groves et al. published a method for synthesizing 1,3-disubstituted cycloalkanes catalyzed by manganese, as shown in the journal Angew.Chem.Int.Ed.2018,57,1251-1255. However, this method uses heavy metal manganese as a catalyst, which is highly toxic and not conducive to sustainable development. In addition, the product is a simple chlorinated or fluorinated 1,3-difunctionalized cycloalkanes, which poses a challenge to the type of substrate and the tolerance of functional groups.

[0008]

[0009] In recent years, strain-release driven reactions have become increasingly powerful methods for constructing challenging molecular frameworks, such as the cobalt-catalyzed functionalization of electrophilic strained molecules reported in 2020. See the journal J.Am.Chem.Soc.2020,142,5355-5361. This method synthesizes a series of 1,3-disubstituted cycloalkanes by reacting a four-membered strained ring substrate with an electron-withdrawing substituted olefin or iodinated aromatic hydrocarbon, but the cobalt catalyst used is complex in structure, difficult to synthesize, and the reaction is sensitive to water and oxygen.

[0010]

[0011] In view of the defects in the synthesis of cycloalkane compounds in the existing technology, it is necessary to further develop efficient and green synthesis technology with significant industrial advantages. Summary of the invention

[0012] The efficient and green synthesis of 1,3-disubstituted cycloalkane compounds with good functional group tolerance remains challenging. In order to achieve the technical purpose of the present invention, the technical solution of the present invention is:

[0013] The present invention first provides a compound of formula 3, the structural formula of which is:

[0014]

[0015] Among them, R 1 and R 2 Same or different as COOR 4 , Hydrogen, SO2PhX, COR 4 , cyano, phenyl, substituted phenyl, substituted pyridyl (methyl), cyclohexanone, COCH3R 4 , carboxyl, quinolyl or a substituent of the following structure:

[0016] R 3 Hydrogen, SO2PhX, -CO2-C-Ph-OMe, COR 4 ; X = hydrogen, trifluoromethyl, halogen, alkyl, alkoxy; n = 1, 2; R 4 is alkyl (alkyl is methyl, ethyl, isopropyl, tert-butyl), CH2Ph, benzyl, pyridine, phenyl, substituted phenyl (wherein the substituent is hydrogen, alkyl, halogen, cyano, nitro, trifluoromethyl, halogen, alkoxy, pyridyl), NMe2, NHPh; R 5 is hydrogen, halogen, alkenyl, alkynyl, straight-chain or branched alkyl, alkoxy, phenyl, substituted phenyl, -(CH2) n CN, ester, amide, benzyl, COR 4 ; R 6For hydrogen, COOR 4 ; R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

[0017] On the other hand, the present invention provides a method for preparing a compound of formula 3, wherein the compound of formula 3 is prepared by reacting a compound of formula 1 with a compound of formula 2 through a nucleophilic addition reaction in the presence of a catalyst:

[0018]

[0019] Among them, R 1 , R 2 , R 3 , R 4 , R 5 The definitions of and n are the same as above; R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

[0020] The nucleophilic addition reaction structural formula is:

[0021]

[0022] Among them, R 1 , R 2 , R 3 , R 4 , R 5 The definitions of and n are the same as above; R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

[0023] The above-mentioned nucleophilic addition reaction catalyst is DMAP (4-dimethylaminopyridine), 4-PPy (4-pyrrolidinylpyridine) or DIPEA (N,N-diisopropylethylamine), and the most preferred one is DMAP, namely 4-dimethylaminopyridine.

[0024] The amount of the above-mentioned nucleophilic addition reaction catalyst is 3-5%.

[0025] The above-mentioned nucleophilic addition reaction solvent is toluene, acetonitrile, acetone or tetrahydrofuran, and toluene is most preferred.

[0026] The temperature of the nucleophilic addition reaction is room temperature to 130°C, and most preferably 110°C.

[0027] The nucleophilic addition reaction time is 2 hours to 24 hours, and most preferably 16 hours.

[0028] The specific structural formula of the product (compound of formula 3) prepared by the nucleophilic addition reaction can be:

[0029]

[0030]

[0031]

[0032] In a third aspect, the present invention provides a compound of formula 3g prepared by a nucleophilic addition reaction, and a compound of formula 3g-1 prepared by a desulfonylation reaction:

[0033]

[0034] The above-mentioned desulfonylation reaction reagent is magnesium, iron powder or aluminum hydroxide, and magnesium is most preferred.

[0035] The solvent for the desulfonylation reaction is methanol, tetrahydrofuran or dimethylformamide, and methanol is most preferred.

[0036] The temperature of the above desulfonation reaction is 0°C to 65°C, most preferably room temperature.

[0037] The desulfonation reaction time is 2 to 24 hours, and most preferably 16 hours.

[0038] The present invention uses cheap active methylene, methyne compounds and four-membered strained ring substrates as starting materials, and can obtain a series of 1,3-disubstituted cycloalkane compounds and 1,1,3-trisubstituted cycloalkane compounds in high yield through nucleophilic addition in one step only under the catalysis of 5% DMAP. The method shows good functional group tolerance to various electron-withdrawing and electron-donating groups and good selectivity. Most of the main cis products can be obtained at a ratio of more than 8:1, which provides a simple, green and powerful method for the synthesis of multifunctional cycloalkane compounds. DETAILED DESCRIPTION

[0039] In order to further understand the present invention, a polysubstituted cycloalkane compound and a preparation method thereof provided by the present invention are described in detail below in conjunction with examples. It should be understood that these examples are only for further illustrating the features of the present invention in detail, and are not intended to limit the scope of the present invention or the scope of the claims of the present invention.

[0040] Embodiment 1:

[0041] Step 1:

[0042]

[0043] Add 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1a (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) to a dry 50 mL Schlenk tube in sequence; add 2 mL of toluene and continue stirring at 110°C for 16 h; after confirming the reaction is complete by tapping the plate, transfer the reaction solution to a 50 mL single-mouth bottle, then add silica gel, concentrate under reduced pressure and load the sample for column chromatography; use n-Hexane:EA as the eluent, collect the desired eluent and spin dry and vacuum to obtain the corresponding product 3a. (3a, trans:cis=1:12, 54.2 mg, 83% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=7.2Hz,2H),7.62(t,J=7.6Hz,1H),7.52(t,J=7.6Hz, 2H),3.73–3.64(m,7H),3.51(d,J=10.4Hz,1H),2.89–2.77(m,1H),3.38–3.33(m,4H). 13 C NMR(101MHz, CDCl3)δ168.3,137.9,133.8,129.4,128.2,56.4,53.4,52.7,28.9,27.5.HRMS(ESI)calc'd for C 15 H 18 NaO6S[M+Na] + 349.0716, found:349.0718.

[0044] Embodiment 2:

[0045]

[0046] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1b (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3b.

[0047] (3b, trans:cis=1:18, 49.6 mg, 72% yield, white solid); 1 H NMR(400MHz, CDCl3)δ7.79(d,J=7.2Hz,2H),7.60(t,J=7.2Hz,1H),7.50(t,J=7.6Hz,2H), 3.75(s,6H),3.69–3.61(m,1H),3.15–2.99(m,1H),2.61–2.53(m,2H),2.20–2.13(m,2H). 13 C NMR (101MHz, CDCl3) δ165.3 (d, J = 25Hz), 137.6, 133.9, 129.3, 128.2, 93.5 (d, J = 199Hz), 53.5, 52.3, 33.1 (d, J = 24Hz), 23.5 (d, J = 4Hz). 19 F NMR(376MHz,CDCl3)δ-174.9.HRMS(ESI)calc'dfor C 15 H 17 FNaO6S[M+Na] + 367.0622, found:367.0628.

[0048] Embodiment 3:

[0049]

[0050] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1c (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3c.

[0051] (3c, trans:cis=1:9, 65.2 mg, 89% yield, white solid); 1H NMR(400MHz, CDCl3)δ7.80(d,J=7.2Hz,2H),7.61(t,J=7.6Hz,1H),7.51(t,J=7.6Hz,2H),5.58–5.48(m,1H), 5.06–5.03(m,2H),3.75(s,6H),3.62–3.53(m,1H),2.83–2.73(m,1H),2.53–2.43(m,4H),2.26–2.19(m,2H). 13 C NMR(101MHz, CDCl3)δ170.3,138.2,133.7,1,132.1,129.3,128.2,119.6,59.7,52.6,52.4,36.7,31.9,25.6.HRMS(ESI)calc'd for C 18 H 22 NaO6S[M+Na] + 389.1029, found:389.1021.

[0052] Embodiment 4:

[0053]

[0054] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1d (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3d.

[0055] (3d, trans:cis=1:8, 64.7 mg, 95% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.77(d,J=6.8Hz,2H),7.57(t,J=6.8Hz,1H),7.48(d,J=7.2Hz,2H),3.65( s,6H),3.59–3.53(m,1H),2.82–2.72(m,1H),2.43–2.34(m,2H),2.18–2.11(m,2H),1.31(s,3H). 13C NMR(101MHz, CDCl3)δ171.3,138.0,133.6,129.2,128.1,55.2,52.5,52.4,34.0,25.2,17.5.HRMS(ESI)calc'd for C 16 H 20 NaO6S[M+Na] + 363.0873, found:363.0878.

[0056] Embodiment 5:

[0057]

[0058] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1e (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3e.

[0059] (3e, trans:cis=1:8, 49.0 mg, 64% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=6.8Hz,2H),7.62(t,J=7.2Hz,1H),7.52(d,J=7.6Hz,2H),3.74(s,6H),3.63–3.54(m,1H),2 .92–2.82(m,1H),2.49–2.40(m,2H),2.25–2.19(m,2H),1.76(d,J=6.0Hz,2H),1.58–1.48(m,H),0.82(s,3H),0.80(s,3H). 13 C NMR(101MHz, CDCl3)δ171.2,138.3,133.7,129.3,128.3,59.4,52.5(2C),40.4,32.3,25.9,24.4,23.7.HRMS(ESI)calc'd forC 16 H 27 O6S[M+H] + 383.1523, found:383.153.

[0060] Embodiment 6:

[0061]

[0062] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1f (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3f.

[0063] (3f, trans:cis=1:10, 46.6 mg, 64% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.79(d,J=7.2Hz,2H),7.60(t,J=7.2Hz,1H),7.50(d,J=7.6Hz,2H),3.75(s,6H),3.66–3.5 6(m,1H),3.13–3.04(m,1H),2.68(d,J=2.8Hz,2H),2.50–2.42(m,2H),2.32–2.24(m,2H),1.97(t,J=2.8Hz,1H). 13 C NMR(101MHz, CDCl3)δ169.4,138.1,133.7,129.3,128.2,78.4,71.7,59.0,52.9,52.2,31.7,25.6,23.5.HRMS(ESI)calc'd for C 18 H 21 O6S[M+H] + 365.1053; Found 365.1055.

[0064] Embodiment 7:

[0065]

[0066] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1 g (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming that the reaction was complete by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the eluate was spin-dried and vacuumed to obtain 3 g of the corresponding product.

[0067] (3g, trans:cis=1:9, 77.8mg, 90% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.79(d,J=7.6Hz,2H),7.61(t,J=7.2Hz,1H),7.50(t,J=7.6Hz,2H),7.16(d,J=8.8Hz,2H),6.83( d,J=9.2Hz,2H),3.79(s,6H),3.78(s,3H),3.66–3.58(m,1H),3.32–3.23(m,1H),2.55–2.48(m,2H),2.31–2.24(m,2H). 13 C NMR(101MHz, CDCl3)δ170.4,159.1,138.2,133.7,129.3,129.1,128.3,127.5,113.8,64.5,55.3,52.9(2C),34.7,26.6.HRMS(ESI)calc'd for C 22 H 24 NNaO7S[M+Na] + 455.1135, found:455.1150.

[0068] Embodiment 8:

[0069]

[0070] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1h (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto and the mixture was stirred continuously at 110°C for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3h.

[0071] (3h, trans:cis=1:20, 45.6mg, 64% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.85(d,J=7.2Hz,2H),7.64(t,J=7.2Hz,1H),7.54(t,J=7.6Hz,2H),3.78( s,6H),3.65–3.56(m,1H),3.44(s,3H),2.91–2.83(m,1H),2.72–2.64(m,2H),2.17–2.10(m,2H). 13 C NMR(101MHz, CDCl3)δ168.4,138.0,133.7,129.3,128.6,84.4,55.4,52.8(2C),34.5,24.5.HRMS(ESI)calc'd for C 16 H 20 NaO7S[M+Na] + 379.0822, found:379.0814.

[0072] Embodiment 9:

[0073]

[0074] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1i (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3i.

[0075] (3i, trans:cis=1:11, 61.7 mg, 87% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.83(d,J=7.2Hz,2H),7.63(t,J=7.2Hz,1H),7.53(t,J=7.2Hz,2H),4.16(q,J=7.2Hz, 4H),3.74–3.65(m,1H),3.48(d,J=10.4Hz,1H),2.89–2.78(m,1H),2.40-2.35(m,4H),1.24(t,J=7.2Hz,6H). 13 C NMR(101MHz, CDCl3)δ167.9,138.1,133.8,129.4,128.3,61.6,56.9,53.6,29.0,27.7,14.2.HRMS(ESI)calc'd for C 17 H 22 NaO6S[M+Na] + 377.1029, found:377.1060.

[0076] Embodiment 10:

[0077]

[0078] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1j (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3j.

[0079] (3j, trans:cis=1:17, 51.3 mg, 63% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.83(d,J=7.2Hz,2H),7.65(t,J=7.2Hz,1H),7.55(t,J=7.6Hz,2H),4.32–4.25(m,4H),3.66–3.57(m,1 H),2.83–2.73(m,1H),2.58–2.50(m,2H),2.44(t,J=7.6Hz,2H),2.30–2.23(m,2H),2.10(t,J=7.6Hz,2H),1.33–1.26(m,6H). 13 C NMR(101MHz, CDCl3)δ169.2,138.1,133.9,129.5,128.3,119.9,62.3,58.6,52.3,33.2,28.4,25.6,14.2,13.3.HRMS(ESI)calc'd for C 20 H 25 NNaO6S[M+Na] + 430.1295,found:430.1303.

[0080] Embodiment 11:

[0081]

[0082] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1k (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3k.

[0083] (3k, trans:cis=1:1, 57.1 mg, 72% yield, colourless oil); 1 H NMR(400MHz, CDCl3)major: δ7.81(d,J=7.2Hz,2H),7.62(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),4.3 4–4.28(m,4H),3.69–3.62(m,1H),3.14–3.08(m,1H),2.63–2.55(m,2H),2.35–2.74(m,5H); minor:δ 7.81(d,J=7.2Hz,0.9H),7.65(t,J=7.6Hz,0.45H),7.52(t,J=7.6Hz,1H),4.17–4.12(m,1.9H),3.28 –3.26(m,0.47H),3.14–3.08(m,0.47H),3.03–2.98(m,0.87H),2.53–2.48(m,0.95H),2.38(s,1.6H). 13 C NMR (101MHz, CDCl3) major: δ198.9,166.6,138.3,133.7,129.4,128.2,72.9,62.7,53.4,31.7,28.9,26.6,1 4.1; minor: δ202.7,167.8,135.0,134.5,129.5,129.2,71.9,61.7,55.9,31.1,27.5,14.2.HRMS(ESI)calc'd forC 19 H 24 NNaO7S[M+Na] + 419.1135, found:419.1139.

[0084] Embodiment 12:

[0085]

[0086] To a dry 50mL Schlenk tube, 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85mg, 0.2mmol, 1.0eq.), 1l (0.6mmol, 3.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3l was obtained by spin drying and vacuuming.

[0087] (3l, trans:cis=1:1, 72.4 mg, 88% yield, solid); 1 H NMR (400MHz, CDCl3) δ7.87(d,J=7.2Hz,0.75H),7.81(d,J=7.2Hz,1.22H),7.63(d,J=7.6Hz,1H),7.53(d,J=7.6Hz,2H),6.78(s,0.58H),6.72 (s,0.35H),4.28–4.19(m,4H),3.62–3.31(m,2H),2.62–2.41(m,3H),2 .27–2.20(m,1H),2.07(s,1.84H),2.03(s,1.12H),1.28–1.22(m,6H). 13 C NMR (101MHz, CDCl3) δ169.9,169.8,167.2,167.1,138.2,137.9,133.8,129.4(2C),128.5,128.3,6 7.4,67.3,62.9,62.8,54.4,52.5,36.5,33.2,24.9,24.3,23.3,23.2,14.1(2C).HRMS(ESI)calc'd for C 19 H 25 NNaO7S[M+Na] + 434.1244, found:434.1327.

[0088] Embodiment 13:

[0089]

[0090] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1m (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3m.

[0091] (3m, trans:cis=1:10, 60.5mg, 68% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.82(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),7.23–7.20(m,3H),7.03–7.00 (m,2H),4.30–4.21(m,4H),3.59–3.51(m,1H),3.14(s,2H),2.60–2.55(m,3H),2.29–2.21(m,2H),1.31(t,J=7.2Hz,6H). 13 C NMR(101MHz, CDCl3)major:δ170.0,138.3,135.7,133.7,129.8,129.3,128.5,128.2,127.2,61.8,60.9,52.4,37.9,31.1,25.7,14.2.HRMS(ESI)calc'd for C 24 H 28 NaO6S[M+Na] + 467.1499,found:467.1516.

[0092] Embodiment 14:

[0093]

[0094] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1n (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3n was obtained by spin drying and vacuuming.

[0095] (3n, trans:cis=1:9, 66.5 mg, 87% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.83(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),5.05–4.95(m,2 H),3.73–3.64(m,1H),3.39(d,J=10.4Hz,1H),2.86–2.74(m,1H),2.38-2.32(m,4H),1.22-1.89(m,12H). 13 C NMR(101MHz, CDCl3)δ166.8,138.1,133.8,129.4,128.2,69.2,57.4,53.7,29.0,27.8,21.8,20.4.HRMS(ESI)calc'd for C 19 H 26 NaO6S[M+Na] + 405.1342, found:405.1340.

[0096] Embodiment 15:

[0097]

[0098] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1o (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3o.

[0099] (3o, trans:cis=1:7, 44.3 mg, 54% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.85(d,J=7.2Hz,2H),7.64(t,J=7.6Hz,1H),7.54(t,J=7.6Hz,2H),3. 77–3.65(m,1H),3.28(d,J=10.4Hz,1H),2.81–2.69(m,1H),2.38-2.34(m,4H),1.44(s,18H). 13 C NMR(101MHz, CDCl3)δ167.4,138.3,133.8,129.4,128.3,82.0,59.0,53.9,29.2,28.1,27.9.HRMS(ESI)calc'd for C 21 H 30 NaO6S[M+Na] + 433.1655,found:433.1653.

[0100] Embodiment 16:

[0101]

[0102] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1p (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3p.

[0103] (3p, trans:cis=1:13, 84.2 mg, 88% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.52(t,J=7.6Hz,2H),7.33–7.3 0(m,6H),7.28–7.25(m,4H),5.13(s,4H),3.69–3.60(m,2H),2.90–2.83(m,1H),2.41–2.29(m,4H). 13 C NMR (101MHz, CDC l3 )δ167.6,138.0,135.3,133.8,129.4,128.7,128.5,128.3,67.4,56.9,53.6,29.1,27.7.HRMS(ESI)calc'd for C 27 H 26 KO6S[M+Na] + 517.1082, found:517.1096.

[0104] Embodiment 17:

[0105]

[0106] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1q (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3q.

[0107] (3q, trans:cis=1:10, 47.7 mg, 81% yield, white solid); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),3.84(d,J=1 0.8Hz,1H),3.74–3.66(m,1H),2.95–2.83(m,1H),2.39–2.30(m,2H),2.25–2.17(m,2H),2.14(s,6H). 13 C NMR(101MHz, CDCl3)δ202.3,137.9,133.9,129.4,128.2,74.3,53.7,30.0,28.5,27.9.HRMS(ESI)calc'd for C 15 H 18 NaO4S[M+Na] + 317.0818, found:317.0814.

[0108] Embodiment 18:

[0109]

[0110] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1r (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3r.

[0111] (3r, 47.7 mg, 57% yield, colourless oil); 1 H NMR(400MHz, CDCl3)δ8.00(d,J=7.2Hz,4H),7.82(t,J=7.2Hz,2H),7.64–7.44(m,9H ),5.53(d,J=10.4Hz,2H),3.77–3.69(m,1H),3.29–3.18(m,1H),2.46–2.34(m,4H). 13 C NMR(101MHz, CDCl3)δ194.7,138.0,136.4,133.9(2C),129.4,129.1,128.9,128.2,62.4,54.2,30.8,28.0.HRMS(ESI)calc'dfor C 25 H 22 NaO4S[M+Na] + 441.1131, found:441.1171.

[0112] Embodiment 19:

[0113]

[0114] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1s (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3s was obtained by spin drying and vacuuming.

[0115] (3s, trans:cis=1:3, 81.4 mg, 83% yield, solid); 1 H NMR(400MHz, CDCl3)major: δ7.89–7.83(m,6H),7.71–7.64(m,3H),7.58–7.53(m,6H),4 .77(d,J=10.8Hz,1H),3.72–3.63(m,1H),2.91–2.77(m,3H),2.56–2.49(m,2H),2.31–2. 24(m,2H); minor: δ7.96–7.94(m,4H),7.87–7.84(m,2H),7.75–7.71(m,2H),7.68–7.54 (m,7H),4.56(d,J=9.2Hz,1H),3.76–3.70(m,1H),3.36–3.28(m,1H),2.82–2.65(m,4H). 13 C NMR (101MHz, CDCl3) major: δ138.3,137.8,134.9,134.1,129.6,129.5,129.3,128.3,86.8,54.6,29.8,26.8 ;Minor: δ138.1,137.4,135.0,134.1,129.7,129.5,129.3,128.5,87.2,55.2,29.5,28.5.HRMS(ESI)calc'd for C 23 H 22 KO6S3[M+Na] + 529.0210,found:529.0206.

[0116] Embodiment 20:

[0117]

[0118] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1t (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3t.

[0119] (3t, 55.0mg, 78% yield, solid); 1 H NMR (400MHz, CDCl3) δ7.82(d,J=7.2Hz,2H),7.62(t,J=7.2Hz,1H),7.62(t,J=7.6Hz,2H),3.93(d,J=10.4Hz ,1H),3.73–3.65(m,1H),3.08–2.91(m,1H),3.06(s,6H),2.93(s,6H),2.47–2.39(m,2H),2.34–2.26(m,2H). 13 C NMR(101MHz, CDCl3)δ168.1,138.1,133.8,129.4,128.2,54.3,53.8,37.3,36.1,30.6,27.8.HRMS(ESI)calc'd for C 17 H 24 N2NaO4S[M+Na] + 375.1349, found:375.1364.

[0120] Embodiment 21:

[0121]

[0122] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1u (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3u.

[0123] (3u, 55.9mg, 90% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.82(d,J=7.2Hz,2H),7.63(t,J=7.2Hz,1H),7.53(t,J=7.6Hz,2H), 3.71(s,3H),3.70–3.65(m,2H),2.91–2.80(m,1H),2.42–2.32(m,3H),2.24–2.18(m,4H). 13C NMR(101MHz, CDCl3)δ201.4,168.6,138.1,133.9,129.4,128.2,64.5,53.7,52.7,30.0,28.4,27.9,27.6.HRMS(ESI)calc'd for C 15 H 19 O5S[M+H] + 311.0948, found:311.0945.

[0124] Embodiment 22:

[0125]

[0126] To a dry 50mL Schlenk tube, 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85mg, 0.2mmol, 1.0eq.), 1v (0.6mmol, 3.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL of toluene was added, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3v was obtained by spin drying and vacuum extraction.

[0127] (3v, 41.3mg, 60% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.84(d,J=7.2Hz,2H),7.62(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),7.33–7.27(m,3H),7.26–7.22( m,2H),3.69–3.61(m,5H),2.97–2.85(m,1H),2.52–2.44(m,1H),2.40–2.32(m,1H),2.20–2.12(m,1H),2.04–1.96(m,1H). 13 C NMR(101MHz, CDCl3)δ173.0,138.3,136.5,133.8,129.4,128.9,128.3,128.1,127.8,57.3,53.2,52.2,32.5,28.6,27.0.HRMS(ESI)calc'dfor C 19 H 20 NaO4S[M+Na] +367.0975,found:367.0971.

[0128] Embodiment 23:

[0129]

[0130] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1w (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3w.

[0131] (3w, 52.1mg, 77% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=7.2Hz,2H),7.62(d,J=7.2Hz,1H),7.52(d,J=7.6Hz,2H),4.42–4.32(m,2H),3.72(s,3 H),3.70–3.64(m,1H),3.13–3.04(m,1H),2.73–2.65(m,1H),2.60–2.55(m,1H),2.46–2.33(m,3H),2.22–2.15(m,1H). 13 C NMR(101MHz, CDCl3)δ173.3,169.5,137.8,133.9,129.4,128.1,66.40,56.2,53.3,52.7,31.9,28.6,26.0,24.1.HRMS(ESI)calc'd for C 16 H 18 NaO6S[M+Na] + 361.0716, found:361.0735.

[0132] Embodiment 24:

[0133]

[0134] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1x (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming that the reaction was complete by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3x was obtained by spin drying and vacuuming.

[0135] (3x, 37.1 mg, 50% yield, solid); 1 H NMR (400MHz, CDCl3) δ8.13 (s, 1H), 7.87 (d, J = 7.6Hz, 2H), 7.65 (t, J = 7.2Hz, 1H),7.55(t,J=7.6Hz,2H),7.47(d,J=7.2Hz,2H),7.32(t,J=7.6Hz,2H),7.1 2(t,J=7.6Hz,1H),3.80–3.72(m,1H),3.57(d,J=10.4Hz,1H),3.29–3.18(m ,1H),2.85–2.67(m,2H),2.33–2.26(m,1H),2.29(s,3H),2.23–2.15(m,1H). 13 C NMR(101MHz, CDCl3)δ206.7,164.5,137.8,137.3,134.0 129.5,129.2,128.5,125.0,120.1,66.6,54.4,32.5,30.7,27.1,26.9.HRMS(ESI)calc'd for C 20 H 21 NaO4S[M+Na] + 394.1083, found:394.1069.

[0136] Embodiment 25:

[0137]

[0138] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1y (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3y.

[0139] (3y, 39.9 mg, 54% yield, solid); 1 H NMR(400MHz, CDCl3) δ7.83(d,J=7.6Hz,2H),7.66–7.60(m,3H),7.54(t,J=7.6Hz,2H),7.38(t,J=7.6Hz, 2H),3.76(d,J=11.2Hz,1H),3.69–3.65(m,4H),2.95–2.84(m,1H),2.53–2.36(m,2H),2.17–1.97(m,2H). 13 C NMR(101MHz, CDCl3)δ171.9,141.7,138.1,133.9,132.8,129.5,129.1,128.3,118.6,112.0,57.1,53.1,52.6,32.4,28.5,26.7.HRMS(ESI)calc'd for C 20 H 19 NaO4S[M+Na] + 392.0927,found:392.0925.

[0140] Embodiment 26:

[0141]

[0142] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1z (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3z.

[0143] (3z, trans:cis=1:1,76.2mg,70%yield,solid); trans: 1 H NMR (400MHz, CDCl3) δ7.76(d,J=7.6Hz,2H),7.61(t,J=7.2Hz,1H),7.50(t,J=7.6Hz,2H),7.38(d,J=2Hz,1H),7.28(d,J=2Hz,1H),7.10 –7.00(m,3H),3.63–3.54(m,1H),3.36–3.26(m,1H),2.43–2.35(m,1H),2.29–2.21(m,7H),2.17–2.05(m,2H),1.43(s,9H),1.41(s,9H). 13 C NMR (101MHz, CDCl3) δ177.3,149.2,147.4,138.2,137.2,136.7,134.5,133.8,133.6,130.2,129.4,128.4,128.3 ,127.7,124.7,123.7,120.8,56.4,53.0,37.1,35.1,34.6,31.8,29.8,26.4,25.4,20.2,19.5.HRMS(ESI)calc'd for C 34 H 40 NaO4S[M+Na] + 567.2540,found:567.2539.cis: 1H NMR (400MHz, CDCl3) δ7.84(d,J=7.2Hz,2H),7.62(t,J=7.2Hz,1H),7.52(t,J=7.6Hz,2H),7.31(d,J=2.4Hz,1H),7.10–6.99(m,4H),3.75–3. 66(m,1H),3.58–3.51(m,1H),2.72–2.57(m,2H),2.49–2.41(m,1H),2 .23(s,3H),2.22(s,3H),2.04–1.97(m,2H),1.42(s,9H),1.30(s,9H). 13 C NMR (101MHz, CDCl3) δ177.6,148.8,147.5,137.9,137.3,136.5,134.8,133.8,133.6,130.3,129.4,128.4,128.3 ,128.2,124.4,123.4,119.0,56.8,53.5,37.6,35.0,34.5,31.7,29.7,24.8,23.9,20.1,19.4.HRMS(ESI)calc'd forC 34 H 40 NaO4S[M+Na] + 567.2540, found:567.2537.

[0144] Embodiment 27:

[0145]

[0146] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1aa (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3aa.

[0147] (3aa, trans:cis=1:3, 31.1 mg, 50% yield, colourless oil); 1H NMR (400MHz, CDCl3) δ7.87–7.84(m,2H),7.66–7.62(m,1H),7.57–7.52(m,2H),7.38–7.24(m,5H),3.88(d,J=9.6Hz,1H),3.82–3.74(m,0.27 H),3.70–3.62(m,0.76H),3.14–3.07(m,0.28H),2.73–2.62(m,1.27H ),2.50–2.44(m,1.39H),2.39–2.27(m,1.29H),2.21–2.12(m,0.77H). 13 C NMR(101MHz, CDCl3)δ137.6(2C),134.0(2C),133.3,133.2,129.5(2C),129.4,129.3,128.7,128.6,128.4 ,128.3,127.5,127.4,119.2,53.7,52.4,42.5,42.2,35.5,34.3,27.6,27.0,26.4,25.9.HRMS(ESI)calc'd for C 18 H 17 NNaO2S[M+Na] + 334.0872, found:334.0876.

[0148] Embodiment 28:

[0149]

[0150] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ab (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3ab.

[0151] (3ab, 47.2 mg, 69% yield, solid); 1H NMR (400MHz, CDCl3) δ7.87(d,J=7.2Hz,2H),7.65(t,J=7.6Hz,1H),7.55(t,J=7.6Hz,2H),7.36–7.30(m,2H),7.2 4(d,J=6.8Hz,1H),7.11(t,J=7.6Hz,1H),5.31(s,2H),3.81–3.72(m,2H),2.85–2.74(m,1H),2.66–2.44(m,4H). 13 C NMR(101MHz, CDCl3)δ171.0,138.0,133.9,132.8,131.7,129.5,129.0,128.3,127.7,125.9,125.3,69.6,53.7,51.1,29.3,28.9,27.6.HRMS(ESI)calc'd for C 19 H 18 NaO4S[M+Na] + 365.0818, found:365.0823.

[0152] Embodiment 29:

[0153]

[0154] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ac (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3ac.

[0155] (3ac, 49.7 mg, 72% yield, colourless oil); 1H NMR (400MHz, CDCl3) δ8.55–8.53(m,1H),7.83(d,J=7.2Hz,2H),7.67–7.65(m,1H ),7.63(t,J=7.2Hz,1H),7.53(t,J=7.6Hz,2H),7.26(d,J=7.6Hz,1H),7.21–7.1 8(m,1H),3.90(d,J=10.8Hz,1H),3.72–3.63(m,1H),3.66(s,3H),3.16–3.05(m, 1H),2.56–2.47(m,1H),2.44–2.36(m,1H),2.26–2.18(m,1H),2.09–2.01(m,1H). 13 C NMR(101MHz, CDCl3)δ171.8,156.2,149.8,138.2,137.2,133.8,129.4,128.3,123.8,122.7,58.8,53.5,52.4,31.4,28.7,26.9.HRMS(ESI)calc'd forC 18 H 19 NNaO4S[M+Na] + 368.0927, found:368.0924.

[0156] Embodiment 30:

[0157]

[0158] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ad (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3ad.

[0159] (3ad, trans:cis=1:1.5,42.1mg,50%yield,colourless oil); trans: 11H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 7.6 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 7.52 (t, J = 7.6 Hz, 2H), 7.31–7.27 (m, 6H), 7.14–7.11 (m, 4H), 3.95–3.87 (m, 1H), 3.70 (s, 3H), 3.16–3.08 (m, 1H), 2.78–2.71 (m, 2H), 2.29–2.22 (m, 2H). 13 13C NMR (101 MHz, CDCl3) δ 174.0, 141.1, 138.1, 133.7, 129.4, 129.3, 128.4, 128.1, 127.4, 62.9, 53.6, 52.6, 36.4, 25.5. HRMS (ESI) calc’d for C 25 H 24 NaO4S [M+Na] + 443.1288, found: 443.1291. cis: 1 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 7.2 Hz, 2H), 7.58 (t, J = 7.2 Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.32–7.28 (m, 6H), 7.14–7.12 (m, 4H), 3.73 (s, 3H), 3.66–3.52 (m, 2H), 2.29 (t, J = 9.2 Hz, 4H). 13 13C NMR (101 MHz, CDCl3) δ 173.9, 140.7, 138.2, 133.5, 129.4, 129.2, 128.3, 128.1, 127.4, 62.6, 53.9, 52.5, 35.7, 26.9. HRMS (ESI) calc’d for C 25 H 24 NaO4S [M+Na] + 443.1288, found: 443.1290.

[0160] Example 31:

[0161]

[0162] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ae (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3ae.

[0163] (3ae, trans:cis=1:10, 56.1 mg, 80% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.81(d,J=7.2Hz,2H),7.62(t,J=7.2Hz,1H),7.52(t,J=7.6Hz,2H),3.80(s,3H),3.64–3.56(m,1H),2.77– 2.68(m,1H),2.49–2.32(m,5H),2.25–2.14(m,2H),2.03–1.97(m,1H),1.81–1.73(m,1H),1.62–1.52(m,2H),1.41–1.33(m,1H). 13 C NMR(101MHz, CDCl3)δ207.2,170.9,138.2,133.7,129.3,128.3,62.5,52.9,52.8,41.2,33.5,33.0,27.4,26.0,24.7,22.5.HRMS(ESI)calc'd for C 18 H 22 NaO5S[M+Na] + 373.1080, found:373.1170.

[0164] Embodiment 32:

[0165]

[0166] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1af (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3af.

[0167] (3af, trans:cis=1:6.3, 61.8 mg, 80% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ8.00(d,J=7.2Hz,2H),7.83(d,J=7.2Hz,2H),7.65–7.58(m,2H),7.55–7.47(m,4H),4.51(d,J=10.4Hz,1 H),4.11(q,J=7.2Hz,2H),3.78–3.69(m,1H),3.15–3.06(m,1H),2.56–2.36(m,3H),2.23–2.15(m,1H),1.14(t,J=7.6Hz,3H). 13 C NMR(101MHz, CDCl3)δ193.8,168.3,138.1,136.4,133.9,133.8,129.4,128.9,128.8,128.3,61.8,59.4,53.9,29.3,28.0,27.5,14.1.HRMS(ESI)calc'd for C 21 H 22 NaO5S[M+Na] + 409.1080, found:409.1075.

[0168] Embodiment 33:

[0169]

[0170] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ag (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3ag was obtained by spin drying and vacuuming.

[0171] (3ag, 55.6mg, 66% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.93(d,J=7.2Hz,2H),7.82(d,J=7.2Hz,2H),7.62(t,J=7.6Hz,1H),7.52(t,J=7.6Hz,2H),7.45(d,J=7.2Hz,2H),4.47 (d,J=10.4Hz,1H),4.10(q,J=7.2Hz,2H),3.78–3.69(m,1H),3.15–3.04(m,1H),2.54–2.35(m,3H),2.20–2.13(m,1H),1.14(t,J=7.6Hz,3H). 13 C NMR(101MHz, CDCl3)δ192.6,168.0,140.5,138.0,134.6,133.8,130.2,129.4,129.2,128.2,61.8,59.3,53.8,29.1,27.8,27.3,14.1.HRMS(ESI)calc'd for C 21 H 21 ClNaO5S[M+Na] + 443.0690,found:443.0632.

[0172] Embodiment 34:

[0173]

[0174] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ah (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3ah was obtained by spin drying and vacuuming.

[0175] (3ah, trans:cis=1:14, 69.8mg, 75% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.87–7.81(m,4H),7.65–7.61(m,3H),7.93(t,J=7.6Hz,2H),4.47(d,J=10.8Hz,1H),4.10(q ,J=7.2Hz,2H),3.78–3.69(m,1H),3.16–3.05(m,1H),2.55–2.36(m,3H),2.21–2.13(m,1H),1.14(t,J=7.2Hz,3H). 13 C NMR(101MHz, CDCl3)δ192.8,168.0,138.1,135.1,133.9,132.3,130.3,129.4,129.3,128.2,61.9,59.3,53.8,29.2,27.9,27.4,14.1.HRMS(ESI)calc'd for C 21 H 21 BrNaO5S[M+Na] + 487.0185,found:487.0166.

[0176] Embodiment 35:

[0177]

[0178] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ai (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3ai.

[0179] (3ai, trans:cis=1:11, 68.1 mg, 85% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.90–7.88(m,2H),7.82–7.81(m,2H),7.62(t,J=6.8Hz,1H),7.52(t,J=7.6Hz,2H),7.27(d,J=7.6Hz,2H),4.48(d, J=10.8Hz,1H),4.09(q,J=7.2Hz,2H),3.77–3.68(m,1H),3.16–3.04(m,1H),2.54–2.34(m,6H),2.22–2.14(m,1H),1.14(t,J=7.2Hz,3H). 13 CNMR (101MHz, CDCl3) δ193.3,168.4,144.9,138.1,133.9,133.8,129.6,129.4, 128.9,128.2,61.6,59.2,53.8,29.3,27.9,27.5,21.8,14.1.HRMS(ESI)calc'd for C 22 H 24 NaO5S[M+Na] + 423.1237, found:423.1218.

[0180] Embodiment 36:

[0181]

[0182] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1aj (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3aj was obtained by spin drying and vacuuming.

[0183] (3aj, trans:cis=1:9, 62.3 mg, 77% yield, white solid); 1 H NMR (400MHz, CDCl3) δ8.06–8.02(m,2H),7.83(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),7.16(t,J=7.6Hz,2H),4.49(d ,J=10.4Hz,1H),4.11(q,J=7.2Hz,2H),3.78–3.70(m,1H),3.17–3.08(m,1H),2.53–2.37(m,3H),2.21–2.16(m,1H),1.15(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ192.2, 168.2, 166.3 (d, J = 254Hz), 138.1, 133.9, 132.8 (d, J = 3Hz), 13 1.6(d,J=10Hz),129.5,128.3,116.1(d,J=23Hz),61.9,59.4,53.9,29.2,27.9,27.4,17.1. 19 F NMR(376MHz,CDCl3)δ-103.6.HRMS(ESI)calc'd for C 21 H 21 FNaO5S[M+Na] + 427.0986,found:427.0983.

[0184] Embodiment 37:

[0185]

[0186] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ak (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3ak was obtained by spin drying and vacuuming.

[0187] (3ak, 44.9 mg, 58% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ8.83(d,J=6.0Hz,2H),7.82(d,J=7.2Hz,2H),7.75(d,J=6.0Hz,2H),7.63(t,J=7.2Hz,1H),7.52(t,J=7.6Hz,2H),4.49 (d,J=10.4Hz,1H),4.10(q,J=7.2Hz,2H),3.78–3.70(m,1H),3.14–3.03(m,1H),2.56–2.38(m,3H),2.21–2.13(m,1H),1.13(t,J=7.2Hz,3H). 13 C NMR(101MHz, CDCl3)δ193.6,167.6,151.2,142.2,138.0,133.9,129.4,128.2,121.4,62.1,59.5,53.8,28.9,27.8,27.3,14.0.HRMS(ESI)calc'd for C 20 H 22 NO5S[M+Na] + 388.1213, found:388.1216.

[0188] Embodiment 38:

[0189]

[0190] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1al (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluent was collected and then spin-dried and vacuumed to obtain the corresponding product 3al.

[0191] (3al, trans:cis=1:7, 51.1 mg, 65% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.84(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),7.25–7.23(m,3H),7.15–7.12(m,1H),4.19 –4.04(m,2H),3.70–3.59(m,2H),2.93–2.81(m,1H),2.51–2.34(m,2H),2.18–2.10(m,1H),2.06–1.97(m,1H),1.20(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ171.9,138.5,138.2,134.7,133.8,130.1,129.4,128.3,1 28.2,128.0,126.5,61.3,57.0,53.1,32.5,28.4,27.1,14.3.HRMS(ESI)calc'd for C 20 H 21 ClNaO4S[M+Na] + 415.0741,found:415.0740.

[0192] Embodiment 39:

[0193]

[0194] To a dry 50mL Schlenk tube, 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85mg, 0.2mmol, 1.0eq.), 1am (0.6mmol, 3.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3am was obtained by spin drying and vacuuming.

[0195] (3am, trans:cis=1:8, 48.8mg, 58% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.84(d,J=7.2Hz,2H),7.65(t,J=7.6Hz,1H),7.56–7.50(m,3H),7.45–7.40(m,2H),7.37–7.33(m,1H),4.47(d,J= 10.8Hz,1H),4.09(q,J=7.2Hz,2H),3.78–3.69(m,1H),3.10–2.98(m,1H),2.51–2.41(m,3H),2.34–2.28(m,1H),1.13(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ196.5,167.7,138.3,138.1,133.9,132.4,131.4,130.9,129 .5(2C),128.3,127.1,62.8,61.8,54.0,29.1,28.0,27.9,14.1.HRMS(ESI)calc'd forC 21 H 21 ClNaO5S[M+Na] + 443.0690,found:443.0684.

[0196] Embodiment 40:

[0197]

[0198] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1an (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3an was obtained by spin drying and vacuuming.

[0199] (3an, trans:cis=1:10, 63.6 mg, 70% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ8.10(d,J=8.4Hz,2H),7.84–7.82(m,2H),7.76(d,J=8.4Hz,2H),7.64(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),4.54(d ,J=10.4Hz,1H),4.11(q,J=7.2Hz,2H),3.79–3.71(m,1H),3.18–3.08(m,1H),2.58–2.39(m,3H),2.22–2.15(m,1H),1.14(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ193.0, 167.9, 139.0, 138.1, 135.1 (q, J = 33Hz), 133.9, 129.5, 129. 1,128.3,126.0(q,J=4Hz),123.6(q,J=271Hz),62.1,59.6,53.9,29.1,27.9,27.4,14.1. 19 F NMR(376MHz,CDCl3)δ-63.2.HRMS(ESI)calc'd for C 22 H 21 F3NaO5S[M+Na] + 477.0954,found:477.0945.

[0200] Embodiment 41:

[0201]

[0202] To a dry 50mL Schlenk tube, 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85mg, 0.2mmol, 1.0eq.), 1ao (0.6mmol, 3.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL of toluene was added, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the product 3ao was obtained by spin drying and vacuuming.

[0203] (3ao, trans:cis=1:5, 38.0 mg, 44% yield, yellow oil); 1 H NMR (400MHz, CDCl3) δ8.33(d,J=8.8Hz,2H),8.16(d,J=8.8Hz,2H),7.83(d,J=7.2Hz,2H),7.64(t,J=7.6Hz,1H),7.54(t,J=7.6Hz,2H),4.57 (d,J=10.4Hz,1H),4.12(q,J=7.2Hz,2H),3.80–3.72(m,1H),3.19–3.07(m,1H),2.58–2.42(m,3H),2.23–2.16(m,1H),1.15(t,J=7.2Hz,3H). 13 CNMR(101MHz, CDCl3)δ192.6,167.7,150.8,140.8,138.1,134.0,129.8,129.5,128.3,124.1,62.2,59.8,53.9,29.1,27.9,27.3,14.1.HRMS(ESI)calc'd for C 21 H 21 NNaO7S[M+Na] + 454.0931,found:454.0921.

[0204] Embodiment 42:

[0205]

[0206] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ap (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, the desired eluate was collected, and then the mixture was spin-dried and vacuumed to obtain the corresponding product 3ap.

[0207] (3ap, trans:cis=1:5, 48.2 mg, 61% yield, yellow oil); 1 H NMR (400MHz, CDCl3) δ8.86–8.85(m,1H),8.10(d,J=7.6Hz,1H),8.02(d,J=7.6Hz,1H) ,7.83–7.78(m,2H),7.67(d,J=2.0Hz,1H),7.59–7.54(m,2H),7.50–7.45(m,2H),7.3 8–7.35(m,1H),6.96(d,J=7.2Hz,2H),3.84(d,J=11.2Hz,1H),3.71–3.64(m,1H),3.6 2(s,3H),3.06–2.94(m,1H),2.53–2.35(m,2H),2.20–2.13(m,1H),2.01–1.93(m,1H). 13 C NMR (101MHz, CDCl3) δ172.5,150.6,147.7,138.0,136.0,134.7,133.7,130.1,129.3,1 29.2,128.3,128.1,127.2,121.5,57.0,53.0,52.3,32.3,28.5,26.8.HRMS(ESI)calc'd for C 22 H 22 NO4S[M+Na] + 396.1264, found:396.1210.

[0208] Embodiment 43:

[0209]

[0210] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1aq (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the mixture was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3aq.

[0211] (3aq, trans:cis=1:10, 72.5 mg, 87% yield, solid); 1 H NMR (400MHz, CDCl3) δ8.00(d,J=8.8Hz,2H),7.84–7.82(m,2H),7.63(t,J=7.6Hz,1H),7.53(t,J=7.6Hz,2H),6.96(d,J=7.2Hz,2H),4.47(d,J=10 .4Hz,1H),4.11(q,J=7.2Hz,2H),3.89(s,3H),3.77–3.69(m,1H),3.17–3 .06(m,1H),2.54–2.34(m,3H),2.22–2.15(m,1H),1.16(t,J=7.2Hz,3H). 13 CNMR (101MHz, CDCl3) δ192.1,168.5,164.3,138.2,133.8,131.3,129.5,129.4, 128.3,114.2,61.7,59.1,55.7,53.9,29.4,27.9,27.6,14.2.HRMS(ESI)calc'd for C 22 H 24 NaO6S[M+Na] + 439.1186, found:439.1175.

[0212] Embodiment 44:

[0213]

[0214] 2a 1-(phenylsulfonyl)bicyclo[1,1,0]butane (38.85 mg, 0.2 mmol, 1.0 eq.), 1ar (0.6 mmol, 3.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added to a dry 50 mL Schlenk tube in sequence; 2 mL of toluene was added thereto, and the mixture was heated at 110°C and stirred for 16 h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50 mL single-necked bottle, and then silica gel was added thereto. After concentrating under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then spin-dried and vacuumed to obtain the corresponding product 3ar.

[0215] (3ar, trans:cis=1:6, 58.0 mg, 60% yield, solid); 1 H NMR (400MHz, CDCl3) δ8.12(d,J=8.4Hz,1H),7.83(d,J=7.2Hz,2H),7.61(d,J=7.6Hz,2H),7.53–7.49(m,3H),7.32(t,J=7.6Hz,1H),7.24(t, J=7.6Hz,1H),3.91(d,J=10.8Hz,1H),3.74–3.69(m,1H),3.65(s,3H),3.13–3.04(m,1H),2.55–2.39(m,2H),2.25–2.09(m,2H),1.67(s,9H). 13 C NMR (101MHz, CDCl3) δ172.6,149.6,138.1,133.8,129.3,128.3,124.8,124.0,122. 9,119.4,115.6,115.5,84.1,53.1,52.3,48.5,31.3,28.3,27.4.HRMS(ESI)calc'd for C 26 H 26 NNaO6S[M+Na] + 506.1608, found:506.1617.

[0216] Embodiment 45:

[0217] Step 2

[0218]

[0219] To a dry 50mL Schlenk tube, dimethyl malonate 1a (79.3mg, 0.6mmol, 3.0eq.), 2b (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3as.

[0220] (3as, trans:cis=1:1, 54.7 mg, 78% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.25–7.22(m,4H),6.85–6.82(m,4H),5.03(s,2H),4.99(s,2H),3.75(s,6H),3.67(s,6H),3.66(s,6H) ,3.42(d,J=10.4Hz,1H),3.39(d,J=10.4Hz,1H),3.09–2.96(m,3H),2.87–2.76(m,1H),2.48–2.33(m,4H),2.11–2.01(m,4H). 13 C NMR (101MHz, CDCl3) δ175.1,174.3,168.5,168.4,159.6,129.9(2C),128.1(2C),113.9,66 .1,66.0,57.0,56.5,55.1,52.3(2C),34.4,34.3,31.7,30.5,30.0,28.8.HRMS(ESI)calc'd for C 18 H 22 NaO7S[M+Na] + 373.1258, found:373.1304.

[0221] Embodiment 46:

[0222]

[0223] To a dry 50mL Schlenk tube, 1a dimethyl malonate (79.3mg, 0.6mmol, 3.0eq.), 2c (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added and stirred continuously at 110°C for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added thereto, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3at.

[0224] (3at, trans:cis=1:2, 54.7 mg, 92% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.87(d,J=7.2Hz,2H),7.54(t,J=7.2Hz,1H),7.43(d,J=7.6Hz,2H),3.96–3.83(m,1H),3.72(s,2H),3 .71(s,4H),3.55(d,J=10.0Hz,0.35H),3.40(d,J=10.4Hz,0.7H),3.06–2.95(m,1H),2.66–2.47(m,2H),2.26–2.16(m,2H). 13 C NMR(101MHz, CDCl3)δ200.3,200.2,168.8(2C),135.5,135.3,133.2,133.1,128.8, 128.4,57.3,56.9,52.6,52.5,38.5,38.2,31.3,30.7,30.1,28.6.HRMS(ESI)calc'd for C 16 H 18 NNaO5S[M+Na] + 313.1046, found:313.1046.

[0225] Embodiment 47:

[0226]

[0227] To a dry 50mL Schlenk tube, 1a dimethyl malonate (79.3mg, 0.6mmol, 3.0eq.), 2d (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added and stirred continuously at 110°C for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added thereto, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3au.

[0228] (3au, trans:cis=1:11, 58.5mg, 81% yield, solid); 1 H NMR (400MHz, CDCl3) δ7.77(d,J=8.4Hz,2H),7.51(d,J=8.4Hz,2H),3.71(s,6H), 3.71–3.64(m,1H),3.52(d,J=10.0Hz,1H),2.91–2.80(m,1H),2.42–2.31(m,4H). 13 C NMR(101MHz, CDCl3)δ168.3,140.7,136.6,129.8,56.4,53.6,52.7,29.0,27.7.HRMS(ESI)calc'd for C 15 H 17 ClNaO6S[M+Na] + 383.0327, found:383.0328.

[0229] Embodiment 48:

[0230]

[0231] To a dry 50mL Schlenk tube, dimethyl malonate 1a (79.3mg, 0.6mmol, 3.0eq.), 2e (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3av.

[0232] (3av, trans:cis=1:11, 55.1 mg, 80% yield, solid); 1 H NMR (400MHz, CDCl3) δ7.92–7.88(m,2H),7.30–7.24(m,2H),3.76(s,6H),3.7 5–3.68(m,1H),3.59(d,J=10.0Hz,1H),2.96–2.85(m,1H),2.48–2.36(m,4H). 13 C NMR (101MHz, CDCl3) δ168.3, 166.1 (d, J = 255Hz), 134.2 (d, J = 3Hz), 131.2 (d, J = 10Hz), 116.8 (d, J = 22Hz), 56.4, 53.7, 52.7, 29.0, 27.7. 19 FNMR(376MHz,CDCl3)δ-103.4.HRMS(ESI)calc'd for C 15 H 17 FNaO6S[M+Na] + 367.0622,found:367.0622.

[0233] Embodiment 49:

[0234]

[0235] To a dry 50mL Schlenk tube, dimethyl malonate 1a (79.3mg, 0.6mmol, 3.0eq.), 2f (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added and stirred continuously at 110°C for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added thereto, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3aw.

[0236] (3aw, trans:cis=1:11, 71.8 mg, 91% yield, solid); 1 H NMR(400MHz, CDCl3) δ7.99(d,J=8.0Hz,2H),7.82(d,J=8.0Hz,2H),3.73(s,6H), 3.76–3.68(m,1H),3.55(d,J=10.0Hz,1H),2.95–2.83(m,1H),2.43–2.39(m,4H). 13C NMR (101MHz, CDCl3) δ168.2, 141.7, 135.6 (q, J = 33Hz), 128.9, 126.6 (q, J = 4Hz), 123.2 (q, J = 271Hz), 56.3, 53.4, 52.7, 29.1, 27.5. 19 F NMR (376MHz, CDCl3) δ-63.3.

[0237] Embodiment 50:

[0238]

[0239] To a dry 50mL Schlenk tube, dimethyl malonate (79.3mg, 0.6mmol, 3.0eq.), 2g (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) of 1a were added in sequence; 2mL of toluene was added, and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3ax.

[0240] (3ax, trans:cis=1:10, 60.6 mg, 89% yield, colourless oil); 1 H NMR(400MHz, CDCl3)δ7.67(d,J=8.0Hz,2H),7.29(d,J=8.0Hz,2H),3.67(s,6H),3.66–3 .62(m,1H),3.49(d,J=10.4Hz,1H),2.84–2.77(m,1H),3.39(s,3H),2.35–2.26(m,4H). 13 C NMR(101MHz, CDCl3)δ168.4,144.9,135.1,130.0,128.3,56.5,53.6,52.7,29.0,27.7,21.7.HRMS(ESI)calc'd for C 16 H 20 NaO6S[M+Na] + 363.0873,found:363.0872.

[0241] Embodiment 51:

[0242]

[0243] To a dry 50mL Schlenk tube, dimethyl malonate 1a (79.3mg, 0.6mmol, 3.0eq.), 2h (0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added in sequence; 2mL toluene was added and stirred continuously at 110°C for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added thereto, and the mixture was concentrated under reduced pressure and then loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3ay.

[0244] (3ay, trans:cis=1:10, 64.2 mg, 90% yield, colourless oil); 1 H NMR(400MHz, CDCl3)δ7.71(d,J=8.8Hz,2H),6.95(d,J=8.8Hz,2H),3.82(s,3H),3.82(s,3H), 3.67(S,6H),3.65–3.59(m,1H),3.48(d,J=10.4Hz,1H),2.83–2.74(m,1H),2.37–2.25(m,4H). 13 CNMR (101MHz, CDCl3) δ168.2,163.2,130.3,129.4,114.5,56.4,55.7,53.6,52.6,28.8,27.6.

[0245] Embodiment 52:

[0246] Step 3:

[0247]

[0248] To a dry 50 mL Schlenk tube, 1a (0.6 mmol, 3.0 eq.), 2i 1-(phenylsulfonyl)bicyclo[2,1,0]pentane (41.7 mg, 0.2 mmol, 1.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added in sequence;

[0249] 2 mL of toluene was added, and the mixture was stirred for 16 h at 110 °C. After confirming the completion of the reaction, the reaction solution was transferred to a 50 mL single-mouth bottle, and silica gel was added thereto. After vacuum concentration, the sample was loaded for column chromatography. n-Hexane:EA was used as the eluent, and the desired eluate was collected and dried in a vacuum to obtain the corresponding product 3az.

[0250] (3az, 57.9 mg, 85% yield, colourless oil); 1 H NMR (400MHz, CDCl3) δ7.86(d,J=7.2Hz,2H),7.63(t,J=7.6Hz,1H),7.43(d,J=7.6Hz,2H),3.70(s,6H),3.58–3.50(m,1H) ,3.31(d,J=10.0Hz,1H),2.58–2.51(m,1H),2.22–2.11(m,2H),1.92–1.82(m,2H),1.80–1.74(m,1H),1.53–1.43(m,1H). 13 C NMR(101MHz, CDCl3)δ168.9,13837,133.8,129.4,128.5,63.4,56.0,52.6(2C),39.6,31.8,29.9,26.1.HRMS(ESI)calc'd for C 16 H 20 NaO6S[M+Na] + 363.0873,found:363.0875.

[0251] Embodiment 53:

[0252]

[0253] To a dry 50 mL Schlenk tube, 1aj (0.6 mmol, 3.0 eq.), 2i 1-(phenylsulfonyl)bicyclo[2,1,0]pentane (41.7 mg, 0.2 mmol, 1.0 eq.) and 4-dimethylaminopyridine (1.22 mg, 0.01 mmol, 0.05 eq.) were added in sequence;

[0254] 2 mL of toluene was added, and the mixture was stirred for 16 h at 110 °C. After confirming the completion of the reaction, the reaction solution was transferred to a 50 mL single-mouth bottle, and silica gel was added. After vacuum concentration, the sample was loaded for column chromatography. n-Hexane:EA was used as the eluent, and the desired eluate was collected and dried in a vacuum to obtain the corresponding product 3ba.

[0255] (3ba, trans:cis=1:1, 62.3 mg, 65% yield, colourless oil); 1H NMR (400MHz, CDCl3)dr=1:1δ7.89–7.85(m,3H),7.82–7.79(m,1H),7.66–7.59(m,3H),7.57–7.49(m,2H),4.26(d,J=10.4Hz,1H),4.10(q,J=7. 6Hz,2H),3.60–3.52(m,1H),2.87–2.78(m,1H),2.29–2.10(m,2H),1.94 –1.81(m,2H),1.67–1.55(m,1H),1.36–1.28(m,1H),1.16–1.12(m,3H). 13 C NMR (101MHz, CDCl3)dr=1:1δ193.4,193.1,168.5(2C),138.7(2C),135.1,135.0,133.8,133.7,132.3,132.2,130.3,129.4(2 C),129.3,128.5,128.4,63.4,63.3,61.8,59.1,58.7,39.8,39.5,32.1,31.6,30.2,29.8,26.3,26.0,14.1.HRMS(ESI)calc'd forC 23 H 23 BrNaO5S[M+Na] + 501.0342,found:501.0344.

[0256] Embodiment 54:

[0257]

[0258] 1as (0.6mmol, 3.0eq.), 2i 1-(phenylsulfonyl)bicyclo[2,1,0]pentane (41.7mg, 0.2mmol, 1.0eq.) and 4-dimethylaminopyridine (1.22mg, 0.01mmol, 0.05eq.) were added to a dry 50mL Schlenk tube in sequence; 2mL toluene was added and the mixture was heated at 110°C and stirred for 16h; after confirming the completion of the reaction by tapping the plate, the reaction solution was transferred to a 50mL single-mouth bottle, and then silica gel was added to the reaction solution. After the reaction was concentrated under reduced pressure, the sample was loaded for column chromatography; n-Hexane:EA was used as the eluent, and the desired eluate was collected and then dried and vacuumed to obtain the corresponding product 3bb.

[0259] (3bb, trans:cis=1:1, 35.3 mg, 41% yield, colourless oil); 1H NMR (400MHz, CDCl3)dr=1:1δ8.00(d,J=7.2Hz,2H),7.90(d,J=7.6Hz,1H),7.8 2(d,J=7.6Hz,1H),7.67–7.49(m,3H),6.95(d,J=8.8Hz,2H),4.26(d,J=10.4Hz ,1H),4.11(q,J=7.6Hz,2H),3.88(s,3H),3.62–3.52(m,1H),2.89–2.80(m,1H ),2.28–2.09(m,2H),1.96–1.86(m,2H),1.82–1.56(m,2H),1.18–1.14(m,3H). 13 C NMR (101MHz, CDCl3)dr=1:1δ192.7,192.4,169.1,169.0,164.3,138.9(2C),133.8,133.7,131.3,129.5,129.4(2C),128.5(2 C),114.2,114.1,63.6,63.4,61.6,58.9,58.4,55.7,40.0,39.8,32.3,31.9,30.3,29.9,26.3,26.0,14.2.HRMS(ESI)calc'd for C 23 H 26 NaO6S[M+Na] + 453.1342, found:453.1345.

[0260] Embodiment 55:

[0261] Step 4

[0262]

[0263] To a dry 100mL round-bottom flask, 3g (432.5mg, 1.0mmol, 1.0eq.), chopped magnesium strips (972.4mg, 40.0mmol, 40.0eq.) and methanol (50mL) were added in sequence; the mixture was continuously shaken in an ultrasonic instrument until continuous bubbles were generated, and then stirred at room temperature for 4h; after the plate was turned to confirm that the reaction was complete, a saturated NH4Cl solution was added to the reaction solution to quench it; the reaction solution was extracted ten times with dichloromethane, and the organic phases were combined and anhydrous MgSO4 was added to remove water and then filtered; an appropriate amount of silica gel was added to the filtrate, and the sample was spin-dried and n-Hexane:EA=20:1 was used as the eluent. After the desired eluent was collected, it was spin-dried and vacuumed to obtain a yellow oily liquid 3g-1, a total of 289.7mg, with a yield of 52%.

[0264] (3g-1, 289.7 mg, 52% yield, yellow oil); 1 H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 8.4 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 3.79 (s, 3H), 3.75 (s, 6H), 3.44–3.35 (m, 1H), 2.06–1.91 (m, 4H), 1.88–1.78 (m, 1H), 1.69–1.62 (m, 1H). 13 C NMR (101 MHz, CDCl3) δ 171.2, 158.8, 129.3, 129.0, 113.6, 65.2, 55.3, 52.5, 40.7, 25.4, 17.5. HRMS (ESI) calc’d for C 16 H 20 NaO5 [M+Na] + 315.1203, found: 315.1202.

Claims

1. A compound of formula 3, characterized in that The structural formula is: Among them, R 1 and R 2 Same or different as COOR 4 , Hydrogen, SO2PhX, COR 4 , cyano, phenyl, substituted phenyl, substituted pyridyl (methyl), cyclohexanone, COCH3R 4 , carboxyl, quinolyl or a substituent of the following structure: R 3 Hydrogen, SO2PhX, -CO2-C-Ph-OMe, COR 4 ; X = hydrogen, trifluoromethyl, halogen, alkyl, alkoxy; n = 1, 2; R 5 is hydrogen, halogen, alkenyl, alkynyl, straight-chain or branched alkyl, alkoxy, phenyl, substituted phenyl, -(CH2) n CN, ester, amide, benzyl, COR 4 ; Among them, R 4 is alkyl, NMe2, NHPh, benzyl, pyridine, phenyl, substituted phenyl, wherein the substituent in the substituted phenyl is hydrogen, alkyl, halogen, cyano, nitro, trifluoromethyl, halogen, alkoxy, pyridyl; R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

2. A method for preparing the compound of formula 3 as claimed in claim 1, characterized in that: In the presence of a catalyst, the compound of formula 1 and the compound of formula 2 are reacted by a nucleophilic addition reaction to obtain a compound of formula 3: Among them, R 1 , R 2 , R 3 , R 4 , R 5 and n are the same as those in claim 1, R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

3. The preparation method according to claim 2, characterized in that: The nucleophilic addition reaction structural formula is: Among them, R 1 , R 2 , R 3 , R 4 , R 5 and n are the same as those in claim 1, R 1 , R 2 , R 3 , R 5 Any two substituents cannot be hydrogen at the same time.

4. The preparation method according to claim 2, characterized in that: The nucleophilic addition reaction catalyst is dimethylaminopyridine, 4-pyrrolidinopyridine or diisopropylethylamine.

5. The preparation method according to claim 2 or 3, characterized in that: The dosage of the nucleophilic addition reaction catalyst is 3-5%.

6. The preparation method according to claim 2, characterized in that: The nucleophilic addition reaction solvent is toluene, acetonitrile, acetone or tetrahydrofuran.

7. The preparation method according to claim 2, characterized in that: The nucleophilic addition reaction temperature is 20°C to 130°C.

8. A method for preparing a compound of formula 3g-1, characterized in that: The compound of formula 3g-1 is prepared from the compound of formula 3g under the action of a sulfone removal reagent, 9. The preparation method according to claim 8, characterized in that: The sulfone removal agent is magnesium, iron powder or aluminum hydroxide.

10. The preparation method according to claim 8, characterized in that: The method is carried out in the presence of a solvent, which is methanol, tetrahydrofuran or dimethylformamide.

Citation Information

Cited By

  • Quaternary cycloalkylated quaternary carbon beta amino acid derivative and preparation method thereof

    CN119528778A